FHL2 silencing also decreased the expression of c-Myc, which is involved in cell proliferation, and Wnt5a and Wnt10b, which are involved in osteosarcoma severity and invasiveness [22], [23], [24]. This evidence concerns the gene WNT5A and osteosarcoma.